Results 11 to 20 of about 8,922 (205)

RNA editing at a limited number of sites is sufficient to prevent MDA5 activation in the mouse brain.

open access: yesPLoS Genetics, 2021
Adenosine deaminase acting on RNA 1 (ADAR1), an enzyme responsible for adenosine-to-inosine RNA editing, is composed of two isoforms: nuclear p110 and cytoplasmic p150.
Jung In Kim   +11 more
doaj   +1 more source

ADAR1-dependent editing regulates human β cell transcriptome diversity during inflammation

open access: yesFrontiers in Endocrinology, 2022
IntroductionEnterovirus infection has long been suspected as a possible trigger for type 1 diabetes. Upon infection, viral double-stranded RNA (dsRNA) is recognized by membrane and cytosolic sensors that orchestrate type I interferon signaling and the ...
Florian Szymczak   +9 more
doaj   +1 more source

Expression and clinical significance of adenosine deaminase acting on RNA-1 in lung adenocarcinoma

open access: yesDi-san junyi daxue xuebao, 2021
Objective To investigate the expression of adenosine deaminase acting on RNA-1 (ADAR1) in lung adenocarcinoma and its association with clinicopathological characteristics and prognosis.
YANG Wendi   +4 more
doaj   +1 more source

ADAR1 interaction with Z-RNA promotes editing of endogenous double-stranded RNA and prevents MDA5-dependent immune activation

open access: yesCell Reports, 2021
Summary: Loss of function of adenosine deaminase acting on double-stranded RNA (dsRNA)-1 (ADAR1) causes the severe autoinflammatory disease Aicardi-Goutières syndrome (AGS). ADAR1 converts adenosines into inosines within dsRNA. This process called A-to-I
Richard de Reuver   +11 more
doaj   +1 more source

ADAR1 has an oncogenic function and can be a prognostic factor in cervical cancer

open access: yesScientific Reports, 2023
Adenosine deaminase acting on RNA 1 (ADAR1), a recently described epigenetic modifier, is believed to play a critical oncogenic role in human cancers. However, its functional role and clinical significance in cervical cancer (CC) remain unclear.
Keiichiro Nakamura   +4 more
doaj   +1 more source

ADAR1 promotes systemic sclerosis via modulating classic macrophage activation

open access: yesFrontiers in Immunology, 2022
IntroductionAs a multisystem autoimmune disorder disease, systemic sclerosis (SSc) is characterized by inflammation and fibrosis in the skin and other internal organs.
Chenming Sun   +5 more
doaj   +1 more source

Protein recoding by ADAR1-mediated RNA editing is not essential for normal development and homeostasis

open access: yesGenome Biology, 2017
Background Adenosine-to-inosine (A-to-I) editing of dsRNA by ADAR proteins is a pervasive epitranscriptome feature. Tens of thousands of A-to-I editing events are defined in the mouse, yet the functional impact of most is unknown. Editing causing protein
Jacki E. Heraud-Farlow   +10 more
doaj   +1 more source

ADAR1 is a prognostic biomarker and is correlated with immune infiltration in lung adenocarcinoma

open access: yesCancer Medicine, 2023
Background Lung adenocarcinoma (LUAD) is a common subtype of non‐small cell lung cancer with high morbidity and mortality rates and is usually detected at advanced stages because of the early onset of metastasis. Adenosine deaminase RNA‐specific 1 (ADAR1)
Wendi Yang   +7 more
doaj   +1 more source

ADAR1 Alleviates Inflammation in a Murine Sepsis Model via the ADAR1-miR-30a-SOCS3 Axis

open access: yesMediators of Inflammation, 2020
Adenosine deaminase acting on double-stranded RNA 1 (ADAR1) mediates adenosine-to-inosine (A-to-I) RNA editing events. ADAR1 is highly expressed in “septic” macrophages and in small intestinal tissues of mice with sepsis.
Zhou Shangxun   +12 more
doaj   +1 more source

ADAR1 as a Placental Innate Immune Rheostat Sustaining the Homeostatic Balance of Intrinsic Interferon Response at the Maternal-Fetal Interface. [PDF]

open access: yesAdv Sci (Weinh)
This study reveals that ADAR1, an RNA‐editing enzyme, fine‐tunes immune responses in the placenta by preventing the accumulation of immunogenic double‐stranded RNAs (dsRNAs) from interferon‐stimulated genes. The loss of ADAR1 in the placenta leads to excessive interferon signaling restricted to the junctional zone, disrupting placental development and ...
Chen X   +7 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy